GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (STU:7AL) » Definitions » Institutional Ownership

Alligator Bioscience AB (STU:7AL) Institutional Ownership : 2.04% (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alligator Bioscience AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alligator Bioscience AB's institutional ownership is 2.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alligator Bioscience AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alligator Bioscience AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Alligator Bioscience AB Institutional Ownership Historical Data

The historical data trend for Alligator Bioscience AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Institutional Ownership Chart

Alligator Bioscience AB Historical Data

The historical data trend for Alligator Bioscience AB can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 2.15 2.08 2.10 2.08 2.13 2.15 2.16 2.16 2.02 2.04

Alligator Bioscience AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Alligator Bioscience AB (STU:7AL) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB (STU:7AL) Headlines

No Headlines